NM_002053.3:c.1757G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002053.3(GBP1):c.1757G>A(p.Arg586Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,613,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002053.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBP1 | ENST00000370473.5 | c.1757G>A | p.Arg586Gln | missense_variant | Exon 11 of 11 | 1 | NM_002053.3 | ENSP00000359504.4 | ||
GBP1 | ENST00000459831.2 | n.2583G>A | non_coding_transcript_exon_variant | Exon 10 of 10 | 3 | |||||
GBP1 | ENST00000484970.1 | n.752G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
GBP1 | ENST00000495131.2 | n.2777G>A | non_coding_transcript_exon_variant | Exon 10 of 10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 152038Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251304Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135834
GnomAD4 exome AF: 0.000145 AC: 212AN: 1461228Hom.: 0 Cov.: 30 AF XY: 0.000138 AC XY: 100AN XY: 726940
GnomAD4 genome AF: 0.0000987 AC: 15AN: 152038Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1757G>A (p.R586Q) alteration is located in exon 11 (coding exon 10) of the GBP1 gene. This alteration results from a G to A substitution at nucleotide position 1757, causing the arginine (R) at amino acid position 586 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at